🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/06/2017 1,47 1,55 1,45 1,53 +6,25% 7,14% 311.600
31/05/2017 1,51 1,52 1,42 1,44 -4,00% 6,62% 1.054.400
30/05/2017 1,55 1,55 1,50 1,50 -2,60% 3,23% 401.700
26/05/2017 1,55 1,58 1,52 1,54 -1,91% 3,94% 433.900
25/05/2017 1,60 1,65 1,54 1,57 -1,88% 6,87% 350.000
24/05/2017 1,65 1,65 1,58 1,60 -2,44% 4,24% 493.200
23/05/2017 1,65 1,66 1,63 1,64 +0,00% 1,82% 378.000
22/05/2017 1,64 1,67 1,59 1,64 +0,00% 4,63% 435.200
19/05/2017 1,62 1,67 1,61 1,64 +0,61% 3,70% 539.200
18/05/2017 1,66 1,69 1,61 1,63 -1,81% 4,64% 700.400
17/05/2017 1,71 1,74 1,63 1,66 -4,60% 6,43% 796.800
16/05/2017 1,73 1,78 1,70 1,74 +0,00% 4,62% 455.300
15/05/2017 1,72 1,77 1,70 1,74 +2,35% 4,07% 641.700
12/05/2017 1,76 1,76 1,67 1,70 -3,95% 5,23% 499.200
11/05/2017 1,71 1,82 1,61 1,77 +4,12% 12,28% 741.000
10/05/2017 1,70 1,72 1,63 1,70 +0,59% 5,29% 533.600
09/05/2017 1,65 1,70 1,56 1,69 +1,81% 8,48% 744.500
08/05/2017 1,74 1,75 1,65 1,66 -5,14% 5,75% 479.200
05/05/2017 1,79 1,79 1,70 1,75 -1,13% 5,03% 739.700
04/05/2017 1,65 2,04 1,60 1,77 +13,46% 26,67% 5.462.400
03/05/2017 1,55 1,59 1,54 1,56 +0,00% 3,23% 362.200
02/05/2017 1,60 1,60 1,53 1,56 -1,27% 4,69% 384.200
01/05/2017 1,54 1,61 1,52 1,58 +1,94% 5,84% 458.800
28/04/2017 1,57 1,59 1,50 1,55 -0,64% 5,73% 641.000
27/04/2017 1,55 1,57 1,50 1,56 +1,96% 4,52% 929.000
26/04/2017 1,52 1,65 1,52 1,53 +0,66% 8,55% 1.787.600
25/04/2017 1,49 1,53 1,48 1,52 +2,70% 3,36% 462.900
24/04/2017 1,55 1,56 1,47 1,48 -2,63% 6,13% 663.700
21/04/2017 1,51 1,55 1,47 1,52 +0,66% 5,30% 448.800
20/04/2017 1,53 1,61 1,50 1,51 +0,00% 7,19% 899.800